Photo Credit: istock.com/artemisdiana
Dr. Eric Rytkin Discussions The Clinical Need For-Aame Significant Advantages of-His Team’s Recently Unveiled Millimeter-Scale, Bioresorbable Pacemaker.
Since Their Debut in the 1960s, Pacemakers have seen ever-growing demand as the cornerstone of cardiac rhythm manager. According to Precept ResearchThe Global Pacemaker Market Reached $ 6.15 Billion in 2024 and is projected to Reach Approximately $ 10.51 Billion by 2034.1 CONCERNTLY, THE INCIDENCE OF PEDIATRIC AGDIANITAL HEART SURGERIES HAS Steadily Climbed Since the 1960s, AS DO AS 2023 Jama Network Open Study.2 Rack These Scale Needs, Pacemaker Technology Remained Fundamentally Unchanged – Until Now.
ENTER ERIC RYTKIN, MD, PHDof Northwestern Universityand Colleagues, who Recently Unveiled A Millimeter-Scale, Bioresorbable Optoelectronic System That integrates with an onboard power supply and a wireless optical control mechanism capable of broad electrotherapeutic applications. Detailed in NatureTheir Pioneering Device Promises to Redefine Cardiac Pacing By Harmlessly Dissolving in Tissue Once its Function is Fulfilled.3 In a Discussion with Physician’s Weekly (PW)Dr. Rytkin Emphasized the clinical need for –and the significant advantages of – this novel system.
PW: What Was Your Inspiration for Developing A Bioresorbable Millimeter-Scale Pacemaker?
Dr. Rytkin: There is an unmet need for transient temporary pacemaker. The ability of the pacemaker to bioresorb overb the period of time will eliminate the need for removal of the device, which is an invasive procedure and, the with any interventional procedure, can be associated with complications. UNFORTUNATELY, this is How the First Man On The Moon, Neil ArmstrongDIED – BLEEDING after the removal of epicardial Wires After the cardiac procedure. ALSO, Such a Tiny Form Factor Will Enable Some Very Interesting Applications and Delivery Options.
What makes this iSUE particularly urgent in the Healthcare Landscape?
The Lack of Recent Progress with Pacemakers is Connering. They may be Bulky, and the Patients May Complain That They have Diffulous Sleeping as It Feels like Thes Are Sleeping on A Cell Phone. The Leadless, Millimeter-Scale Bioresorbable Pacemaker is a Paradigm Shift in Rhythm Management.
Why Will This System Be Particularly Beneficial for Pediatric Patients?
PEDIATRIC PATENTS PRESENT A CHALLENGE BECAUSE THE HART MUSCLE IS EVER-BROWING, AND PERMENT SOLUTIONS Are Quickly Outgrown. Our Bioresorbable Millimeter-Scale Pacemaker Addresses These Challenges. Our Device Will Be a Useful Instrument for congenital Heart Surgeons.
How can the use of this device potentially improve cat?
Reducing Complications Associated with the Removal of the Pacing Leads Cour Potentially Make Right Procedures Procedures. In many instances, patients who have the pacemaker impulsed cannot undergo Mri (Magnetic Resonance Imaging) for the rest of their lives, or physicians are hesitant to order mri scans bocause their are Wary of the interaction beteen the pacemaker’s metal parts and the magnetic Fields. OUR DEVICE IS NOT ONLY COMPATIBLE WITH MRI BUT WILL ALSO BIOORESORB, AND PATIES CAN THERFORE SAFELY UNDERGO MRI SCANS.
Are they any additional device-specific details that physicians should be aware of?
ITS BIOSORPTION RATE IS PROGRAMMABLE, AND IT CAN POTENTIALLY BE USED BY EMS Personnel or IN EMERGENCY ROOMS UNDRED ULEFR GUIDANCE.
What’s Next for You And Your Team?
We have the startup, BIOSYSTEMS NUSEand we are actively works on Commercializing the Devices. So, it won´t be long before they becomed available in the clinic, first as an investigational device and then, we hope, as an stablished solution. We (Also) have Several Applications in Our pipeline, inclusion to TAVR (TRANSCATHETER ARTIC VALVE REPLACMENT) VALVE With a pacing capability, Which Will Address the Issue of Post-Implantation Conduction Problems and Make the Tavr Valve Implantation Procedure an Outpatient One.
